International Pharmaceutical Companies Make Global Impact on H1N1 Vaccine

It's a race against time as international pharmaceuticaltoxicity studies in animals, and hope to work on
companies develop this life-saving vaccine for thehuman clinical trials by December. Their goal is to
deadly H1N1 influenza virus. The U.S. Food and Druglaunch the vaccines before March in order to stay on
Administration recently approved four H1N1 vaccines.track with fellow international pharmaceutical
Pharmaceutical consulting firms point out that thecompanies.
H1NI vaccines are similar to the seasonal flu vaccines.Although, China has already beat out the U.S. and
However, the current seasonal flu vaccines on theIndia and already launched mass vaccinations in
market do not protect people from the H1N1 virus.Beijing. China is the first nation across the globe to
The FDA will continue to conduct clinical studies toinoculate against the H1N1 virus. China's health bureau
determine the proper vaccine dosage for children.states that 500 medical workers in 50 teams have
The vaccines have been tolerated well during clinicalalready been sent out to Beijing schools to inoculate
trials with adults and side effects are similar to thestudents. The H1N1 flu vaccination is free and
seasonal flu vaccine. FDA studies show that thesevoluntary. School children, teachers and those who
four approved vaccines induce a greater immunesuffer from chronic lung and heart conditions are
response in healthy adults eight to ten days aftergiven first priority to receive the shots.
they have been vaccinated (similar to how theChina has already been hit hard by the virus. It
seasonal influenza vaccine works).already shipped vaccines out to eight provinces
The FDA is working closely with the U.S. Center forincluding: Shandong, Guangdong, Hunan and Sichuan.
Disease control and other non-governmental agenciesThese regions have seen the most severe
for further analysis and information sharing. Theoutbreaks. China reports that 31 provinces have
vaccines are expected to be available byalready been affected by the virus. 95 percent of
mid-October and approximately 45 million doses ofH1N1 cases in China have been transmitted
the vaccine will be made available for the public.domestically and not through international travelers
The FDA can't take all the credit for developingvisiting China.
these much-needed, life-saving H1N1 vaccines.Australia and Britain aren't far behind China when it
International pharmaceutical companies in Australia,comes to launching their vaccines on the market.
Switzerland and France are valuable players in theAustralian pharmaceutical companies will begin mass
development of the four vaccines.immunization programs by the end of September.
However, the United States isn't the only countryBritain is scheduled to administer its 100,000 vaccine
working hard to develop H1N1 influenza vaccines.doses by October. Even the country of Jordan is
Pharmaceutical companies in India report they willjumping onboard and bought two million vaccines
launch their H1N1 vaccine before March. With fundingfrom international pharmaceutical companies. Jordan's
provided by the World Health Organization, IndianMinistry of Health reports that the first back of
pharmaceutical companies are currently working onvaccines should be available by November.